Abstract
RESULTS OF LONG-TERM (36 MONTHS) USE OF RITUXIMAB (RTM) AND IMMUNOSUPPRESSANTS (IS) IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) WITH INTERSTITIAL LUNG DISEASE (ILD)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have